Formulations Tri-Moxi* – Single Use Vial

Tri-Moxi* – Single Use Vial

(Triamcinolone/Moxifloxacin)

Proprietary Dropless compounded formulations are combined with our patent pending SSP technology that uniquely allows the combination of drugs.

Now available from our 503B Outsourcing Facility.

Classification Injectable
Sub-classification Intraocular Formulations
Strength (Concentration) common dose* 15mg/1mg/mL
Size (Volume) single-use vial

Order today from our FDA-Registered Outsourcing Facility

Order your prescriptions now.

Order Now

*For professional use only. Imprimis Pharmaceuticals specializes in customizing medications to meet unique patient and practitioner needs. No compounded medication is reviewed by the FDA for safety or efficacy. Imprimis Pharmaceuticals does not compound copies of commercially available products. References available upon request.